Miguel F. Sanmamed - Publications, H-index & Citations

Miguel F. Sanmamed

Department of Oncology

57H指数

467论文数

1.8W被引数

收录论文 95

发表时间

Fulzerasib plus cetuximab in first-line KRASG12C-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial Fulzerasib 联合西妥昔单抗用于一线 KRASG12C 突变非小细胞肺癌（KROCUS）：一项单臂、多中心、Ⅰb/Ⅱ期临床试验

The Lancet Oncology

IF0

2026-03-30

PREAI

Vanesa Gregorc; Margarita Majem; Giuseppe Lo Russo; Michele Maio; Stephanie Salvagni; Vanesa Gutiérrez-Calderon; Maria Gonzalez-Cao; Sergio Sandiego Contreras; Anna Koumarianou; Alessandra Bearz; Reyes Bernabé-Caro; Santiago Viteri; Miguel Fernández de Sanmamed; Flora Zagouri; Teresa Morán Bueno; Chiara Lazzari; Sergio Martínez-Recio; Ana Giménez-Capitán; Yue Zhang; Yue Shan

The impact of excess weight and body fat on clinical outcomes of immune checkpoint inhibitors according to gender 超重和体脂对免疫检查点抑制剂临床结局的影响：按性别分析

Journal of Endocrinological Investigation

IF3.5

2025-10-27

OAAI

Marta García-Goñi; María Olmedo; Adriana García-Goñi; Francisco Guillén-Grima; Juan C. Galofré; Miguel Fernández de Sanmamed

Brief Report: Emphysema as a prognostic factor in advanced NSCLC patients with COPD receiving immune checkpoint inhibitors.简报：肺气肿作为合并COPD的晚期NSCLC患者接受免疫检查点抑制剂治疗时的预后因素。

Journal of Thoracic Oncology

IF20.8

2025-10-21

OAAI

Madeleine Di Frisco; Miguel F. Sanmamed; José María Ferrandez; Anna Vilalta; Miguel Sogbe; Marta García-Goñi; Ángela Martin-Palmero; Samantha Aso-Gonzalez; Ernest Nadal; Jaime Signes-Costa; Valentina Gambardella; Víctor Seguí Manzaneque; Paloma Martin; Amelia Insa; José Franco; Carmen Lores; Juan P. de-Torres

Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients PD-1、LAG-3和TIM-3在肿瘤内CD8 T细胞上的表达与接受阿替利珠单抗治疗的晚期尿路上皮癌患者治疗反应的相关性：一项真实世界证据生物标志物研究

OncoImmunology

IF6.3

2025-08-08

OAAI

Carlos E. de Andrea; Marta Abengozar-Muela; José Ángel Arranz; Miguel Angel Climent; Javier Puente; Ángel Vizcay; Ligia Montero de la Fuente; José Miguel Jurado; Teresa Bonfill; Carmen Santander; José Carlos Villa; Eduardo Pujol; Adriana Carolina Rosero; Jenifer Gomez; Eva María Fernández; Carlos Álvarez Fernández; Ignacio Ramirez; Pablo Arnáiz; Álvaro López-Janeiro; Ignacio Melero; Miguel F. Sanmamed; José Luis Pérez-Gracia

Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors 利菲鲁赛（Lifileucel）肿瘤浸润淋巴细胞细胞疗法在免疫检查点抑制剂治疗后疾病进展的不可切除或转移性黏膜黑色素瘤患者中的应用

Cancer Communications

IF24.9

2025-07-22

OAAI

Harriet Kluger; Götz Ulrich Grigoleit; Sajeve Thomas; Evidio Domingo-Musibay; Jason A Chesney; Miguel F Sanmamed; Theresa Medina; Mirjana Ziemer; Eric Whitman; Friedrich Graf Finckenstein; Brian Gastman; Jeffrey Chou; Xiao Wu; Giri Sulur; Rana Fiaz; Rongsu Qi; Amod A Sarnaik

Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer Vaccines

CANCER DISCOVERY

IF33.3

2024-11-01

PREAI

Berraondo, Pedro; Cuesta, Raquel; Sanmamed, Miguel F.; Melero, Ignacio

Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment

ARCHIVOS DE BRONCONEUMOLOGIA

IF9.2

2024-10-01

OAAI

Orive, Daniel; Echepare, Mirari; Bernasconi-Bisio, Franco; Fernandez Sanmamed, Miguel; Pineda-Lucena, Antonio; de la Calle-Arroyo, Carlos; Detterbeck, Frank; Hung, Rayjean J.; Johansson, Mattias; Robbins, Hilary A.; Seijo, Luis M.; Montuenga, Luis M.; Valencia, Karmele

Phase I trial of the delta-like ligand-3 (DLL3)/CD3 IgG-Like T cell engager BI 764532 in patients (pts) with DLL3-positive tumors: Updated data delta-like ligand-3 (DLL3)/CD3 IgG样T细胞结合剂BI 764532在DLL3阳性肿瘤患者(pts)中的I期试验：更新数据

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Wermke, M.; Gambardella, V.; Kuboki, Y.; Felip, E.; Sanmamed, M. F.; Alese, O.; Sayehli, C. M.; Arriola Aperribay, E.; Wolf, J.; Villaruz, L.; Studeny, M.; Bouzaggou, M.; Fang, X.; Morgensztern, D.

Activity and outcomes of a Translational Research Unit coordinated by nursing 由护理协调的转化研究单元的活动与成果

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Andueza, M. P.; Navarcorena Zabalza, E.; Iragorri Barberena, Y.; Ayensa Burgui, M.; Gracia Ilundain, I.; Navamuel Andueza, I.; Ojer Perea, A.; Navamuel Andueza, M.; Sanmamed, M. F.; Rodriguez-Ruiz, M. E.; Pio, R.; Gonzalez Hernandez, A.; Fortuno, M. A.; de Torres, J. P.; Seijo Maceiras, L. M.; Lozano, M. D.; Melero, I.; Montuenga, L.; Perez Gracia, J. L.; Ocon, M.

Expanding Horizons in Cardiac Transplant: Efficacy and Outcomes of Circulatory and Brain Death Donor Hearts in a Newly Implemented Cardiac Transplant Program with Limited Donor Accessibility and a Literature Review

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-08-23

OAAI

Marco, Maria del Val Groba; Santana, Miriam Cabrera; Ruiz, Mario Galvan; de Sanmamed, Miguel Fernandez; Lujan, Jose Luis Romero; Martin, Jesus Maria Gonzalez; Ortega, Luis Santana; Espinar, Maria Vazquez; Torron, Francisco Portela; Morant, Vicente Pena; Dorta, Eduardo Jose Caballero; Quintana, Antonio Garcia

Thyroid dysfunction caused by immune checkpoint inhibitors improves cancer outcomes

ENDOCRINE-RELATED CANCER

IF4.6

2024-07-16

PREAI

Garcia-Goni, Marta; Gutierrez, Beatriz Vazquez; Sanmamed, Miguel F.; Martin-Algarra, Salvador; Luis Perez-Gracia, Jose; Olmedo, Maria; Chumbiauca, Estefania; Martin-Calvo, Nerea; Galofre, Juan C.

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism

ONCOIMMUNOLOGY

IF6.3

2024-07-09

OAAI

Eguren-Santamaria, Inaki; Rodriguez, Inmaculada; Herrero-Martin, Claudia; de Pierola, Eva Fernandez; Azpilikueta, Arantza; Sanchez-Gregorio, Sandra; Bolanos, Elixabet; Gomis, Gabriel; Molero-Glez, Paula; Chacon, Enrique; Minguez, Jose Angel; Chiva, Santiago; Diez-Caballero, Fernando; de Andrea, Carlos; Teijeira, Alvaro; Sanmamed, Miguel F.; Melero, Ignacio

Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunity

SCIENCE IMMUNOLOGY

IF16.3

2024-04-26

PREAI

Zhang, Tianxiang; Yu, Weiwei; Cheng, Xiaoxiao; Yeung, Jacky; Ahumada, Viviana; Norris, Paul C.; Pearson, Mackenzie J.; Yang, Xuan; van Deursen, Willemijn; Halcovich, Christina; Nassar, Ala; Vesely, Mathew D.; Zhang, Yu; Zhang, Jianping; Ji, Lan; Flies, Dallas B.; Liu, Linda; Langermann, Solomon; LaRochelle, William J.; Humphrey, Rachel; Zhao, Dejian; Zhang, Qiuyu; Zhang, Jindong; Gu, Runxia; Schalper, Kurt A.; Sanmamed, Miguel F.; Chen, Lieping

Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

EBIOMEDICINE

IF10.8

2024-04-01

OAAI

Patino-Garcia, Ana; Guruceaga, Elizabeth; Andueza, Maria Pilar; Ocon, Marimar; Sokoudjou, Jafait Junior Fodop; Zornoza, Nicolas de Villalonga; Alkorta-Aranburu, Gorka; Uria, Ibon Tamayo; Gurpide, Alfonso; Camps, Carlos; Jantus-Lewintre, Eloisa; Navamuel-Andueza, Maria; Sanmamed, Miguel F.; Melero, Ignacio; Elgendy, Mohamed; Fusco, Juan Pablo; Zulueta, Javier J.; de-Torres, Juan P.; Bastarrika, Gorka; Seijo, Luis; Pio, Ruben; Montuenga, Luis M.; Hernaez, Mikel; Ochoa, Idoia; Perez-Gracia, Jose Luis

Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure 第一阶段，TYRP1-TCB的首次人体研究 (RO7293583)，一种新型TYRP1-targeting CD3 T细胞接合器，用于转移性黑色素瘤: 主动药物监测以评估免疫反应对药物暴露的影响

FRONTIERS IN ONCOLOGY

IF3.3

2024-03-21

OAAI

Spreafico, Anna; Couselo, Eva Munoz; Irmisch, Anja; Bessa, Juliana; Au-Yeung, George; Bechter, Oliver; Svane, Inge Marie; Sanmamed, Miguel F.; Gambardella, Valentina; McKean, Meredith; Callahan, Margaret; Dummer, Reinhard; Klein, Christian; Umana, Pablo; Justies, Nicole; Heil, Florian; Fahrni, Linda; Opolka-Hoffmann, Eugenia; Waldhauer, Inja; Bleul, Conrad; Staack, Roland F.; Karanikas, Vaios; Fowler, Stephen

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

NATURE COMMUNICATIONS

IF15.7

2024-01-02

OAAI

Ascierto, Paolo A.; Casula, Milena; Bulgarelli, Jenny; Pisano, Marina; Piccinini, Claudia; Piccin, Luisa; Cossu, Antonio; Mandala, Mario; Ferrucci, Pier Francesco; Guidoboni, Massimo; Rutkowski, Piotr; Ferraresi, Virginia; Arance, Ana; Guida, Michele; Maiello, Evaristo; Gogas, Helen; Richtig, Erika; Fierro, Maria Teresa; Lebbe, Celeste; Helgadottir, Hildur; Queirolo, Paola; Spagnolo, Francesco; Tucci, Marco; Del Vecchio, Michele; Cao, Maria Gonzales; Minisini, Alessandro Marco; De Placido, Sabino; Sanmamed, Miguel F.; Mallardo, Domenico; Paone, Miriam; Vitale, Maria Grazia; Melero, Ignacio; Grimaldi, Antonio M.; Giannarelli, Diana; Dummer, Reinhard; Sileni, Vanna Chiarion; Palmieri, Giuseppe

Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3+tumors: Focus on Asian pts

ANNALS OF ONCOLOGY

IF65.4

2023-11-01

PREAI

Kuboki, Y.; Gambardella, V.; Capdevila Castillon, J.; Alese, O. B.; Morgensztern, D.; Sayehli, C. M.; Sanmamed, M. F.; Arriola, E.; Wolf, J.; Owonikoko, T. K.; Studeny, M.; Bouzaggou, M.; Song, E.; Wermke, M.

Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, combined with osimertinib, as first-line therapy or after progression on osimertinib in non-small cell lung cancer (NSCLC)

ANNALS OF ONCOLOGY

IF65.4

2023-11-01

PREAI

Cappuzzo, F.; Moreno Garcia, V.; Ou, S-H. I.; Brandao, M.; Sanmamed, M. F.; Helissey, C.; Wislez, M.; Call, J. A.; Grisanti, S.; Johnson, M. L.; Boni, V.; Jamme, P.; Monnet, I.; Siena, S.; Yan, C.; Barasa, B.; Richard, B.; Joe, A. K.; Laus, G.; Felip, E.

Identification of 'secondary' germline cancer predisposition variants from somatic tumour testing: Should we evolve towards universal screening?

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Gallego Martinez, A.; Imizcoz, T.; Sanchez-Lorenzo, L.; Mora, M.; Dominguez, D.; Gurpide, A.; Espinos Jimenez, J.; Aramendia, J. M.; Chopitea Ortega, A.; Santisteban Eslava, M.; Ponz-Sarvise, M.; Gonzalez, L.; Landa Magdalena, A.; Sanmamed, M. F.; Alkorta-Aranburu, G.; Rodriguez Rodriguez, J.; Herraiz Bayod, T.; Gonzalez Martin, A.; Patino-Garcia, A.

Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3-positive (+) tumours: Focus on neuroendocrine carcinomas

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Gambardella, V.; Castillon, J. Capdevila; Kuboki, Y.; Alese, O.; Morgensztern, D.; Sayehli, C. M.; Sanmamed, M. F.; Arriola, E.; Hamed, Z. Oum'; Song, E.; Studeny, M.; Wermke, M.

研究方向